Shandong Zhanhua Yonghao
News

Add: GENGJU VILLAGE NORTH ONE KILOMETER,,ZHANHUA DISTRICT,BINZHOU CITY,SHANDONG PROVINCE,CHINA.

+86-543-7596322

Contact Us

News

Comprehensive management to reduce HIV risks

Date: 2022/12/29

-Use DESCOVY FOR PrEP to reduce the risk of HIV-1 infection as part of a comprehensive strategy that includes adherence to daily dosing and safer sex practices, including condoms, to reduce the risk of sexually transmitted infections (STIs)

HIV risk factors

-HIV-1 risk factors: Behavioral, biological, or epidemiologic HIV-1 risk factors may include, but are not limited to: condomless sex, past or current STIs, self-identified HIV risk, having sexual partners of unknown HIV-1 viremic status, or sexual activity in a high-prevalence area or network

-Reduce STI risk: Counsel on the use of STI prevention measures (e.g., consistent and correct condom use, knowledge of partner’s HIV-1 viremic status, regular testing for STIs)

-Reduce potential for drug resistance: Only prescribe DESCOVY FOR PrEP to individuals confirmed to be HIV negative immediately prior to initiation, at least every 3 months while taking DESCOVY, and upon an STI diagnosis. HIV-1 resistance substitutions may emerge in individuals with undetected HIV-1 infection who are taking only DESCOVY because DESCOVY alone is not a complete regimen for treating HIV-1

-Some HIV tests may not detect acute HIV infection. Prior to initiating DESCOVY FOR PrEP, ask individuals about potential recent exposure events. If recent (<1 month) exposures are reported or suspected, or symptoms of acute HIV infection (e.g., fever, fatigue, myalgia, skin rash) are present, confirm HIV-negative status with a test approved by the FDA for use in the diagnosis of acute HIV infection

-If HIV-1 infection is suspected or if symptoms of acute infection are present while taking DESCOVY FOR PrEP, convert the DESCOVY FOR PrEP regimen to a complete HIV treatment regimen until HIV-negative status is confirmed by a test approved by the FDA for use in the diagnosis of acute HIV infection

-Counsel on adherence: Counsel individuals to strictly adhere to daily dosing, as efficacy is strongly correlated with adherence. Some individuals, such as adolescents, may benefit from more frequent visits and counseling

 


Last : Early HIV ... 】 【[ Back ]Next : New PrEP r...


 

Shandong Zhanhua Yonghao pharmaceutical & Tech Co.,Ltd
      Add: GENGJU VILLAGE NORTH ONE KILOMETER,,ZHANHUA DISTRICT,BINZHOU CITY,SHANDONG PROVINCE,CHINA.
      Tel: +86-543-7596322    Fax: +86-543-7596300
      Sales add: C ZONE,7TH F.L.,NEW TAIZHOU BLDG.,TAIZHOU,ZHEJIANG PROVINCE,CHINA
      Sale Tel: +86-576-0576-88685096/88810310/88603655
      Fax: +86-576-88685099
      E-mail: sales@yfchem.cn

Copyright(C)2017,Shandong Zhanhua Yonghao pharmaceutical & Tech Co.,Ltd All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice